0001209191-11-023717.txt : 20110420 0001209191-11-023717.hdr.sgml : 20110420 20110420171302 ACCESSION NUMBER: 0001209191-11-023717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110419 FILED AS OF DATE: 20110420 DATE AS OF CHANGE: 20110420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gillespie Deirdre CENTRAL INDEX KEY: 0001354737 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 11771327 MAIL ADDRESS: STREET 1: 416 MARLBOROUGH STREET STREET 2: APT. 707 CITY: BOSTON STATE: MA ZIP: 02115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 4365 EXECUTIVE DRIVE, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2011-04-19 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001354737 Gillespie Deirdre 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 1 1 0 0 President & CEO Common Stock 2011-04-19 4 S 0 4376 0.70 D 0 D /s/ Deirdre Y. Gillespie 2011-04-20